Literature DB >> 10547589

Tumour vascularity and proliferation: clear evidence of a close relationship.

N Weidner.   

Abstract

Evaluation of various prognostic factors often reveals that some are closely related. In this issue of the Journal of Pathology, evidence is presented linking intratumoural microvessel density with tumour cell proliferation. This is expected, because an adequate blood vascular system is necessary for effective tumour cell proliferation. The blood vascular supply of a tumour is critical not only in providing tumour cells with nutrients, oxygen, and waste elimination, but also because activated endothelial cells release important paracrine growth factors for tumour cells and secrete collagenases, urokinases, and plasminogen activator. The latter allow capillary ingrowth and the spread of tumour cells into and through the adjacent fibrin-gel matrix, connective tissue stroma, and into the lymphatic and/or vascular spaces. Finally, an adequate vascular supply helps to 'switch off' apoptosis and prevent other forms of tumour necrosis, thus contributing to overall tumour growth and spread. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  1999        PMID: 10547589     DOI: 10.1002/(SICI)1096-9896(199911)189:3<297::AID-PATH434>3.0.CO;2-O

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  25 in total

1.  Early prediction of response of sorafenib on hepatocellular carcinoma by CT perfusion imaging: an animal study.

Authors:  Q Wang; G Shi; L Wang; X Liu; R Wu
Journal:  Br J Radiol       Date:  2014-01-27       Impact factor: 3.039

2.  Vascular disrupting effect of CKD-516: preclinical study using DCE-MRI.

Authors:  Kyung Won Kim; Jeong Min Lee; Yong Sik Jeon; In Joon Lee; YoonSeok Choi; Jisuk Park; Berthold Kiefer; Chin Kim; Joon Koo Han; Byung Ihn Choi
Journal:  Invest New Drugs       Date:  2013-01-09       Impact factor: 3.850

3.  Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.

Authors:  Joanna-W Ho; Ronnie-T Poon; Chris-K Sun; Wei-Cheng Xue; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

4.  Canine classical seminoma: a specific malignant type with human classifications is highly correlated with tumor angiogenesis.

Authors:  Jong-Hyuk Kim; Chi-Ho Yu; Ji-Young Yhee; Keum-Soon Im; Na-Hyun Kim; Jung-Hyang Sur
Journal:  BMC Cancer       Date:  2010-05-28       Impact factor: 4.430

5.  The Use of CT Perfusion to Determine Microvessel Density in Lung Cancer: Comparison with FDG-PET and Pathology.

Authors:  Ning Xing; Zu-Long Cai; Shao-Hong Zhao; Li Yang; Bai-Xuan Xu; Fu-Lin Wang
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

6.  Antitumor effect of microbubbles enhanced by low frequency ultrasound cavitation on prostate carcinoma xenografts in nude mice.

Authors:  Yu Wang; Bing Hu; Xuehong Diao; Jizhen Zhang
Journal:  Exp Ther Med       Date:  2011-11-07       Impact factor: 2.447

7.  The Study of MIB-1 LI and CD 34 As A Marker of Proliferative Activity and Angiogenesis in Different Grades of Meningioma.

Authors:  Harishkumar Bohra; Khushi Ram Rathi; Sharmila Dudani; Ashish Bohra; Sumit Vishwakarma; Kavita Sahai
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 8.  Imaging hemodynamics.

Authors:  Dominique Jennings; Natarajan Raghunand; Robert J Gillies
Journal:  Cancer Metastasis Rev       Date:  2008-12       Impact factor: 9.264

9.  [Therapy-related changes of angiogenesis in Philadelphia chromosome positive chronic myelogenous leukemia].

Authors:  H M Kvasnicka; J Thiele; P Staib; K Engels; S Kriener; A Schmitt-Graeff
Journal:  Pathologe       Date:  2004-03       Impact factor: 1.011

10.  Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.

Authors:  C Li; R Gardy; B K Seon; S E Duff; S Abdalla; A Renehan; S T O'Dwyer; N Haboubi; S Kumar
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.